PharmiWeb.com - Global Pharma News & Resources
04-Jul-2019

Liver Cancer Diagnostic Market Size is Projected to Jump USD 15.2 Bn by 2026

The Global Liver Cancer Diagnostic Market Size is expected to reach USD 15.2 Billion by 2026 and growing CAGR around 8.3 % during the forecast period from 2018 to 2026.

The Global Liver Cancer Diagnostic Market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2018 to 2026. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2018 to 2026.

Request a Sample Copy of this Research Report athttps://www.acumenresearchandconsulting.com/request-sample/1039

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the global Liver Cancer Diagnostic Market.

Key Takeaways:

  • What is the market size in 2018 and the growth rate of the global Liver Cancer Diagnostic Market?
  • What is the market drivers, restrains, opportunities governing the global Liver Cancer Diagnostic Market?
  • Which is the largest and the fastest growing segments in the global Liver Cancer Diagnostic Market?
  • Who are the key players operating in the market and their market position?
  • What is the pipeline scenario, drug pricing analysis and technological development in the market?

Market Players:

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market. The Liver Cancer Diagnostic Market is consolidated with large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues.

The major players associated with the Liver Cancer Diagnostic Market are Thermo Fisher Scientific, Illumina, Inc.; Siemens Healthcare GmbH; Qiagen; and F. Hoffmann-La Roche Ltd.

To Purchase this Premium Report at https://www.acumenresearchandconsulting.com/buy-now/0/1039

The Major Market Segments of GlobalLiver Cancer Diagnostic Marketare as below:

Market Segmentation

Market By Screening Type

  • Laboratory Tests
    • Biomarkers
      • Oncofetal and Glycoprotein Antigens
      • Enzymes and Isoenzymes
      • Growth Factors and Receptors
      • Molecular Markers
      • Pathological Biomarkers
    • Blood Tests
  • Imaging
  • Endoscopy
  • Biopsy
  • Others

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Liver Cancer Diagnostic
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Liver Cancer Diagnostic Market By Screening Type
1.2.2.1. Global Liver Cancer Diagnostic Market Revenue and Growth Rate Comparison By Screening Type (2015-2026)
1.2.2.2. Global Liver Cancer Diagnostic Market Revenue Share By Screening Type in 2017
1.2.2.3. Laboratory Tests
1.2.2.4. Imaging
1.2.2.5. Endoscopy
1.2.2.6. Biopsy
1.2.2.7. Others
1.2.3. Liver Cancer Diagnostic Market by Geography
1.2.3.1. Global Liver Cancer Diagnostic Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.3.2. North America Liver Cancer Diagnostic Market Revenue and Growth Rate (2015-2026)
1.2.3.3. Europe Liver Cancer Diagnostic Market Revenue and Growth Rate (2015-2026)
1.2.3.4. Asia-Pacific Liver Cancer Diagnostic Market Revenue and Growth Rate (2015-2026)
1.2.3.5. Latin America Liver Cancer Diagnostic Market Revenue and Growth Rate (2015-2026)
1.2.3.6. Middle East and Africa (MEA) Liver Cancer Diagnostic Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Liver Cancer Diagnostic Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Liver Cancer Diagnostic Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Liver Cancer Diagnostic Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Liver Cancer Diagnostic Major Manufacturers in 2017

CHAPTER 4. LIVER CANCER DIAGNOSTIC MARKET BY SCREENING TYPE

4.1. Global Liver Cancer Diagnostic Revenue By Screening Type
4.2. Laboratory Tests
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Imaging
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Endoscopy
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Biopsy
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Others
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. NORTH AMERICA LIVER CANCER DIAGNOSTIC MARKET BY COUNTRY

5.1. North America Liver Cancer Diagnostic Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2. North America Liver Cancer Diagnostic Market Revenue Share Comparison, 2015 amp; 2026 (%)
5.3. U.S.
5.3.1. U.S. Liver Cancer Diagnostic Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
5.4. Canada
5.4.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
5.5. Mexico
5.5.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 6. EUROPE LIVER CANCER DIAGNOSTIC MARKET BY COUNTRY

6.1. Europe Liver Cancer Diagnostic Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. Europe Liver Cancer Diagnostic Market Revenue Share Comparison, 2015 amp; 2026 (%)
6.3. UK
6.3.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.4. Germany
6.4.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.5. France
6.5.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.6. Spain
6.6.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
6.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.7. Rest of Europe
6.7.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
6.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 7. ASIA-PACIFIC LIVER CANCER DIAGNOSTIC MARKET BY COUNTRY

7.1. Asia-Pacific Liver Cancer Diagnostic Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Asia-Pacific Liver Cancer Diagnostic Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. China
7.3.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4. Japan
7.4.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5. India
7.5.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.6. Australia
7.6.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.7. South Korea
7.7.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.8. Rest of Asia-Pacific
7.8.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
7.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 8. LATIN AMERICA LIVER CANCER DIAGNOSTIC MARKET BY COUNTRY

8.1. Latin America Liver Cancer Diagnostic Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Latin America Liver Cancer Diagnostic Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. Brazil
8.3.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4. Argentina
8.4.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5. Rest of Latin America
8.5.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 9. MIDDLE EAST LIVER CANCER DIAGNOSTIC MARKET BY COUNTRY

9.1. Middle East Liver Cancer Diagnostic Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Middle East Liver Cancer Diagnostic Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. Saudi Arabia
9.3.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4. UAE
9.4.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5. Rest of Middle East
9.5.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 10. AFRICA LIVER CANCER DIAGNOSTIC MARKET BY COUNTRY

10.1. Africa Liver Cancer Diagnostic Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Africa Liver Cancer Diagnostic Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. South Africa
10.3.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4. Egypt
10.4.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5. Rest of Africa
10.5.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 11. COMPANY PROFILE

11.1. Thermo Fisher Scientific
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. Illumina, Inc.
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. Siemens Healthcare GmbH
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. Qiagen
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. F. Hoffmann-La Roche Ltd.
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. Others
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies

CHAPTER 12. RESEARCH APPROACH

12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope

Buy this Premium Research Report at https://www.acumenresearchandconsulting.com/buy-now/0/1039

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 04-Jul-2019